Milestone Pharmaceuticals Inc.
For the period ended Nov 12, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 12, 2025 · Filed Nov 12, 2025
Use the contents to explore the available documents and sections.
MIST$0.76+10.2%Stored close · as of Nov 6, 2026
Contents
CURRENT REPORT
**Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.